CBRE U.S. Healthcare Capital Markets (HCM) is a national practice of seasoned professionals who are dispersed throughout the United States and maintain relationships with the deepest sources of capital that are dedicated to investing in healthcare assets. The group specializes in providing healthcare real estate investors with acquisition, disposition and debt & equity recapitalization strategies across the continuum of care, including medical office buildings, specialized and general acute care, long-term acute care facilities, and other post-acute care operations. Additionally, we assist healthcare organizations with strategic capital planning (including monetization of non-core real estate), and advising owners and operators in the developer selection process.

Led by Chris Bodnar and Lee Asher, HCM was one of the first brokerage teams nationally to form a specialty practice focused on the healthcare investment sector. Since the inception of the group, CBRE has become the leading real estate advisor to the healthcare industry with more healthcare capital markets transactions than any other brokerage firm according to statistics provided by Real Capital Analytics (an independent third party research firm). In 2019, the group was responsible for the disposition of 6.3 million square feet of healthcare real estate across 159 properties. Sales and financings for the year totaled $2.5 billion.



  • Assisting health systems in the monetization of healthcare real estate
  • Advising healthcare providers and physician groups on the selection of developers for healthcare real estate
  • Providing innovative financing solutions through deeply rooted lender relationships
  • Direct hospital lender through the HUD Section 242 Mortgage Insurance Program
  • Conduit financing structures for not-for-profits through the tax-exempt bond market

Featured Content

U.S. Healthcare Capital Markets 2019 Investor & Developer Survey

U.S. Healthcare Capital Markets 2019 Investor & Developer Survey

CBRE U.S. Healthcare Capital Markets is pleased to present the findings of our 2019 Investor & Developer Survey.